Literature DB >> 5151303

Central haemodynamic effects in man of intravenous d-alprenolol during rest and exercise.

L G Ekelund, A Melcher, L Orö.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5151303     DOI: 10.1007/BF00565006

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  15 in total

1.  Circulatory and respiratory adaptation during prolonged exercise.

Authors:  L G Ekelund
Journal:  Acta Physiol Scand Suppl       Date:  1967

Review 2.  Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs.

Authors:  C T Dollery; J W Paterson; M E Conolly
Journal:  Clin Pharmacol Ther       Date:  1969 Nov-Dec       Impact factor: 6.875

3.  Haemodynamic effects of dextro-propranolol in acute myocardial infarction.

Authors:  D Bennet; R Balcon; J Hoy; E Sowton
Journal:  Thorax       Date:  1970-01       Impact factor: 9.139

4.  Hemodynamic effects of alprenolol (H56-28).

Authors:  J D Proctor; F J Allen; A J Wasserman
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-10

5.  Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.

Authors:  A J Wasserman; J D Proctor; F J Allen; V E Kemp
Journal:  J Clin Pharmacol J New Drugs       Date:  1970 Jan-Feb

6.  Effects of a new beta-adrenergic receptor blocking agent, alprenolol, andts optical isomers.

Authors:  R E Belliveau; B G Covino
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-08

Review 7.  Perspectives in adrenergic beta-receptor blockade.

Authors:  J D Fitzgerald
Journal:  Clin Pharmacol Ther       Date:  1969 May-Jun       Impact factor: 6.875

8.  [Velocity of pressure rise in the left ventricle as criterion of contractility under different hemodynamic conditions].

Authors:  C Morgenstern; G Arnold; U Höljes; W Lochner
Journal:  Pflugers Arch       Date:  1970       Impact factor: 3.657

9.  Pharmacological properties of H 56-28--a beta-adrenergic receptor antagonist.

Authors:  B Ablad; M Brogård; L Ek
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1967

10.  Clinical experience with dextro-alprenolol.

Authors:  J K Vohra; P L Thompson; J G Sloman
Journal:  Br Med J       Date:  1970-03-28
View more
  2 in total

Review 1.  Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.

Authors:  D G Gibson
Journal:  Drugs       Date:  1974       Impact factor: 9.546

Review 2.  The clinical pharmacology of beta adrenergic blocking drugs.

Authors:  D G McDevitt; R G Shanks; B N Prichard
Journal:  J R Coll Physicians Lond       Date:  1976-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.